Nevro Corp (NYSE:NVRO)
$ 5.06 -0.26 (-4.89%) Market Cap: 188.65 Mil Enterprise Value: 166.94 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 42/100

Nevro Corp at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 12:30PM GMT
Release Date Price: $20.07 (-0.89%)
Bill Plovanic
Canaccord Adams - Managing Director & senior analysts

Great.

Good morning. My name is Bill Plovanic IMA. is one of Canaccord's senior analysts in the medical technology vertical. Welcome to Canaccord's 43rd Annual Global Growth Conference we are excited to host never with us today we have Kevin torn, CEO. and Rod MacLeod, CFO.

Thank you for joining us, and today's format will be a short five-to-10-minute Company overview presentation. And it will be followed by 15-to-20-minute fireside chat. We'll also be taking live questions from the live audience and with that, Kevin, the podium is yours.

Kevin R. Thornal
Nevro Corp - President, CEO & Director

Perfect. Thanks, Bill, and thanks for having us here today. So, I'm starting off with setting the pace for SCS. When I tell you what SCS So spinal cord stimulation, basically, it's a small little device that has a battery inside of it that's connected to leads that go inside the spinal column and it interrupts the signals from pain from late leg and back pain to your brain.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot